Pfizer and Express Scripts Sign AgreementRebate Agreement • November 6th, 2022
Contract Type FiledNovember 6th, 2022(BUSINESS WIRE)--Express Scripts, Inc. (NASDAQ: ESRX), and Pfizer Inc (NYSE: PFE), today announced an agreement providing for Pfizer’s participation in Express Scripts’ rebate program. Due to improved terms under the agreement, Express Scripts has added Lipitor
Pfizer and Express Scripts Sign AgreementRebate Agreement • October 19th, 2022
Contract Type FiledOctober 19th, 2022(BUSINESS WIRE)--Express Scripts, Inc. (NASDAQ: ESRX), and Pfizer Inc (NYSE: PFE), today announced an agreement providing for Pfizer’s participation in Express Scripts’ rebate program. Due to improved terms under the agreement, Express Scripts has added Lipitor